Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia.

MLA

Craig, Stephanie G., et al. “Immune Status Is Prognostic for Poor Survival in Colorectal Cancer Patients and Is Associated with Tumour Hypoxia.” British Journal of Cancer, vol. 123, no. 8, Oct. 2020, pp. 1280–88. EBSCOhost, https://doi.org/10.1038/s41416-020-0985-5.

APA

Craig, S. G., Humphries, M. P., Alderdice, M., Bingham, V., Richman, S. D., Loughrey, M. B., Coleman, H. G., Viratham-Pulsawatdi, A., McCombe, K., Murray, G. I., Blake, A., Domingo, E., Robineau, J., Brown, L., Fisher, D., Seymour, M. T., Quirke, P., Bankhead, P., McQuaid, S., … Salto-Tellez, M. (2020). Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia. British Journal of Cancer, 123(8), 1280–1288. https://doi.org/10.1038/s41416-020-0985-5

Chicago

Craig, Stephanie G, Matthew P Humphries, Matthew Alderdice, Victoria Bingham, Susan D Richman, Maurice B Loughrey, Helen G Coleman, et al. 2020. “Immune Status Is Prognostic for Poor Survival in Colorectal Cancer Patients and Is Associated with Tumour Hypoxia.” British Journal of Cancer 123 (8): 1280–88. doi:10.1038/s41416-020-0985-5.